SEC Form 4 · accession 0001192482-17-000127
COLLEGIUM PHARMACEUTICAL, INC · COLL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Brannelly
Officer — Executive Vice President & CFO
Period of report
May 12, 2017
Accepted (ET)
May 15, 2017 · 5:26 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267565
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 12, 2017 | P | 10,000 | $9.18 | A | 110,227 | D |
Table II — derivative securities
No Table II lines on this filing.